UniProt ID | UBP10_MOUSE | |
---|---|---|
UniProt AC | P52479 | |
Protein Name | Ubiquitin carboxyl-terminal hydrolase 10 | |
Gene Name | Usp10 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 792 | |
Subcellular Localization | Cytoplasm . Nucleus . Early endosome . Cytoplasmic in normal conditions (By similarity). After DNA damage, translocates to the nucleus following phosphorylation by ATM (By similarity). | |
Protein Description | Hydrolase that can remove conjugated ubiquitin from target proteins such as p53/TP53, BECN1, SNX3 and CFTR. Acts as an essential regulator of p53/TP53 stability: in unstressed cells, specifically deubiquitinates p53/TP53 in the cytoplasm, leading to counteract MDM2 action and stabilize p53/TP53. Following DNA damage, translocates to the nucleus and deubiquitinates p53/TP53, leading to regulate the p53/TP53-dependent DNA damage response. Component of a regulatory loop that controls autophagy and p53/TP53 levels: mediates deubiquitination of BECN1, a key regulator of autophagy, leading to stabilize the PIK3C3/VPS34-containing complexes. In turn, PIK3C3/VPS34-containing complexes regulate USP10 stability, suggesting the existence of a regulatory system by which PIK3C3/VPS34-containing complexes regulate p53/TP53 protein levels via USP10 and USP13. Does not deubiquitinate MDM2. Deubiquitinates CFTR in early endosomes, enhancing its endocytic recycling. Involved in a TANK-dependent negative feedback response to attenuate NF-kappaB activation via deubiquitinating IKBKG or TRAF6 in response to interleukin-1-beta (IL1B) stimulation or upon DNA damage. Deubiquitinates TBX21 leading to its stabilization.. | |
Protein Sequence | MALHNPQYIFGDFSPDEFNQFFVTPRSSVELPPYSGTLCSIQAEDELPDGQEHQRIEFGVDEVIEPSEGLPPTPSYSISSTLNPQAPEFILGCTTSKKIPEAVEKDETYSSIDQYPASALALESNSNAEAETLENDSGAGGLGQRERKKKKKRPPGYYSYLKDGGEDSASPATLVNGHATSVGTSGEAVEDAEFMDVLPPVMPRTCDSPQNPVDFISGPVPDSPFPRTLGGDARTAGLCEGCHEADFEQPCLPADSLLRTAGTQPYVGTDTTENFAVANGKILESPGEDTAANGAELHTDEGADLDPAKPESQSPPAESALSASGAIPISQPAKSWASLFHDSKPSASSPMAYVETKCSPPVPSPLASEKQMEVKEGLVPVSEDPVAIKIAELLETVTLIHKPVSLQPRGLINKGNWCYINATLQALVACPPMYHLMKFIPLYSKVQRPCTSTPMIDSFVRLMNEFTNMPVPPKPRQALGDKIVRDIRPGAAFEPTYIYRLLTVIKSSLSEKGRQEDAEEYLGFILNGLHEEMLSLKKLLSPTHEKHSVSNGPRSDLIEDEELEDTGKGSEDEWEQVGPKNKTSITRQADFVQTPITGIFGGHIRSVVYQQSSKESATLQLFFTLQLDIQSDKIRTVQDALESLVARESVQGYTTKTKQEVEVSRRVTLEKLPPVLVLHLKRFVYEKTGGCQKLVKNIDYPVDLEISRELLSPGIKNKNFKCQRTYRLFAVVYHHGNSATGGHYTTDVFQIGLNGWLRIDDQTVKVINQYQVVKPPADRTAYLLYYRRVDLL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MALHNPQYI ------CCCCCCCEE | 19.96 | - | |
8 | Phosphorylation | MALHNPQYIFGDFSP CCCCCCCEECCCCCH | 10.24 | 26643407 | |
14 | Phosphorylation | QYIFGDFSPDEFNQF CEECCCCCHHHHHCC | 35.86 | 26643407 | |
24 | Phosphorylation | EFNQFFVTPRSSVEL HHHCCEECCCCCCCC | 14.08 | 26643407 | |
27 (in isoform 2) | Phosphorylation | - | 39.68 | 29472430 | |
27 | Phosphorylation | QFFVTPRSSVELPPY CCEECCCCCCCCCCC | 39.68 | 30352176 | |
28 | Phosphorylation | FFVTPRSSVELPPYS CEECCCCCCCCCCCC | 22.38 | 30352176 | |
28 (in isoform 2) | Phosphorylation | - | 22.38 | 29472430 | |
34 (in isoform 2) | Phosphorylation | - | 20.14 | 29472430 | |
35 (in isoform 2) | Phosphorylation | - | 30.95 | 29472430 | |
37 (in isoform 2) | Phosphorylation | - | 20.74 | 29472430 | |
40 (in isoform 2) | Phosphorylation | - | 22.35 | 29472430 | |
110 | Phosphorylation | VEKDETYSSIDQYPA HHCCCCCCCHHHCCH | 28.39 | 25338131 | |
118 | Phosphorylation | SIDQYPASALALESN CHHHCCHHHHHHHCC | 21.22 | 25338131 | |
124 | Phosphorylation | ASALALESNSNAEAE HHHHHHHCCCCHHCE | 46.54 | 25338131 | |
126 | Phosphorylation | ALALESNSNAEAETL HHHHHCCCCHHCEEC | 46.85 | 27087446 | |
132 | Phosphorylation | NSNAEAETLENDSGA CCCHHCEECCCCCCC | 46.55 | 27087446 | |
152 | Malonylation | RERKKKKKRPPGYYS HHHHCCCCCCCCCHH | 78.13 | 26320211 | |
205 | Phosphorylation | LPPVMPRTCDSPQNP CCCCCCCCCCCCCCC | 18.13 | 24925903 | |
208 | Phosphorylation | VMPRTCDSPQNPVDF CCCCCCCCCCCCCCC | 30.45 | 24925903 | |
209 | Phosphorylation | MPRTCDSPQNPVDFI CCCCCCCCCCCCCCC | 25.39 | 24719451 | |
217 | Phosphorylation | QNPVDFISGPVPDSP CCCCCCCCCCCCCCC | 36.72 | 25619855 | |
223 | Phosphorylation | ISGPVPDSPFPRTLG CCCCCCCCCCCCCCC | 23.52 | 24925903 | |
228 | Phosphorylation | PDSPFPRTLGGDART CCCCCCCCCCCCCCC | 29.96 | 23984901 | |
285 | Phosphorylation | ANGKILESPGEDTAA ECCEECCCCCCCCCC | 34.46 | 20469934 | |
290 | Phosphorylation | LESPGEDTAANGAEL CCCCCCCCCCCCCCC | 24.30 | 23649490 | |
299 | Phosphorylation | ANGAELHTDEGADLD CCCCCCCCCCCCCCC | 48.66 | 23140645 | |
312 | Phosphorylation | LDPAKPESQSPPAES CCCCCCHHCCCCHHH | 44.48 | 23140645 | |
314 | Phosphorylation | PAKPESQSPPAESAL CCCCHHCCCCHHHHH | 41.97 | 24453211 | |
319 | Phosphorylation | SQSPPAESALSASGA HCCCCHHHHHHCCCC | 36.29 | 23649490 | |
322 | Phosphorylation | PPAESALSASGAIPI CCHHHHHHCCCCCCC | 21.80 | 24453211 | |
324 | Phosphorylation | AESALSASGAIPISQ HHHHHHCCCCCCCCC | 25.94 | 23140645 | |
330 | Phosphorylation | ASGAIPISQPAKSWA CCCCCCCCCCCCHHH | 25.42 | 20469934 | |
335 | Phosphorylation | PISQPAKSWASLFHD CCCCCCCHHHHHHCC | 29.95 | 23984901 | |
338 | Phosphorylation | QPAKSWASLFHDSKP CCCCHHHHHHCCCCC | 25.88 | 23984901 | |
343 | Phosphorylation | WASLFHDSKPSASSP HHHHHCCCCCCCCCC | 37.59 | 23984901 | |
344 | Acetylation | ASLFHDSKPSASSPM HHHHCCCCCCCCCCC | 49.39 | 23954790 | |
346 | Phosphorylation | LFHDSKPSASSPMAY HHCCCCCCCCCCCEE | 44.51 | 23984901 | |
348 | Phosphorylation | HDSKPSASSPMAYVE CCCCCCCCCCCEEEE | 39.03 | 26643407 | |
349 | Phosphorylation | DSKPSASSPMAYVET CCCCCCCCCCEEEEE | 20.57 | 23984901 | |
353 | Phosphorylation | SASSPMAYVETKCSP CCCCCCEEEEECCCC | 7.80 | 26643407 | |
356 | Phosphorylation | SPMAYVETKCSPPVP CCCEEEEECCCCCCC | 27.57 | 26643407 | |
359 | Phosphorylation | AYVETKCSPPVPSPL EEEEECCCCCCCCCC | 33.52 | 25521595 | |
360 | Phosphorylation | YVETKCSPPVPSPLA EEEECCCCCCCCCCC | 43.29 | 24719451 | |
364 | Phosphorylation | KCSPPVPSPLASEKQ CCCCCCCCCCCCHHH | 32.55 | 22942356 | |
368 | Phosphorylation | PVPSPLASEKQMEVK CCCCCCCCHHHCEEC | 53.67 | 25619855 | |
402 (in isoform 2) | Ubiquitination | - | 39.87 | 22790023 | |
402 | Ubiquitination | ETVTLIHKPVSLQPR HHEEEECCCCCCCCC | 39.87 | 22790023 | |
403 (in isoform 2) | Ubiquitination | - | 13.53 | - | |
445 | Ubiquitination | KFIPLYSKVQRPCTS HHHHHHHHCCCCCCC | 28.91 | 22790023 | |
445 (in isoform 2) | Ubiquitination | - | 28.91 | 22790023 | |
446 (in isoform 2) | Ubiquitination | - | 4.86 | - | |
482 | Acetylation | PRQALGDKIVRDIRP CCCCCCCHHHHCCCC | 41.10 | 6571721 | |
541 | Phosphorylation | LSLKKLLSPTHEKHS HHHHHHHCCCCHHCC | 37.88 | 25521595 | |
543 | Phosphorylation | LKKLLSPTHEKHSVS HHHHHCCCCHHCCCC | 39.01 | 26745281 | |
555 | Phosphorylation | SVSNGPRSDLIEDEE CCCCCCHHHCCCCCH | 39.64 | 25619855 | |
566 | Phosphorylation | EDEELEDTGKGSEDE CCCHHHHCCCCCHHH | 31.27 | 25521595 | |
570 | Phosphorylation | LEDTGKGSEDEWEQV HHHCCCCCHHHHHHC | 45.41 | 24925903 | |
571 | Phosphorylation | EDTGKGSEDEWEQVG HHCCCCCHHHHHHCC | 69.49 | 24719451 | |
616 | Phosphorylation | YQQSSKESATLQLFF EECCCCCCEEEEEEE | 30.23 | 27357545 | |
618 | Phosphorylation | QSSKESATLQLFFTL CCCCCCEEEEEEEEE | 25.06 | 27357545 | |
624 | Phosphorylation | ATLQLFFTLQLDIQS EEEEEEEEEECHHCC | 13.27 | 27357545 | |
631 | Phosphorylation | TLQLDIQSDKIRTVQ EEECHHCCCHHHHHH | 41.00 | 27357545 | |
636 | Phosphorylation | IQSDKIRTVQDALES HCCCHHHHHHHHHHH | 26.45 | 22345495 | |
643 | Phosphorylation | TVQDALESLVARESV HHHHHHHHHHHHHHH | 29.06 | 22345495 | |
649 | Phosphorylation | ESLVARESVQGYTTK HHHHHHHHHCCCCCC | 17.75 | 30635358 | |
653 | Phosphorylation | ARESVQGYTTKTKQE HHHHHCCCCCCCCCE | 8.31 | 30635358 | |
654 | Phosphorylation | RESVQGYTTKTKQEV HHHHCCCCCCCCCEE | 28.74 | 30635358 | |
655 | Phosphorylation | ESVQGYTTKTKQEVE HHHCCCCCCCCCEEE | 28.38 | 30635358 | |
656 | Ubiquitination | SVQGYTTKTKQEVEV HHCCCCCCCCCEEEE | 46.02 | 27667366 | |
657 | Phosphorylation | VQGYTTKTKQEVEVS HCCCCCCCCCEEEEE | 35.55 | 30635358 | |
657 | Ubiquitination | VQGYTTKTKQEVEVS HCCCCCCCCCEEEEE | 35.55 | 27667366 | |
664 | Phosphorylation | TKQEVEVSRRVTLEK CCCEEEEECCCCHHH | 10.81 | 30635358 | |
671 | Ubiquitination | SRRVTLEKLPPVLVL ECCCCHHHCCCEEEE | 70.21 | 22790023 | |
671 (in isoform 2) | Ubiquitination | - | 70.21 | 22790023 | |
672 (in isoform 2) | Ubiquitination | - | 4.18 | - | |
681 | Ubiquitination | PVLVLHLKRFVYEKT CEEEEEEEHHHHHHC | 32.80 | 27667366 | |
682 | Ubiquitination | VLVLHLKRFVYEKTG EEEEEEEHHHHHHCC | 32.40 | 27667366 | |
687 | Malonylation | LKRFVYEKTGGCQKL EEHHHHHHCCCCHHH | 34.48 | 26320211 | |
696 | Ubiquitination | GGCQKLVKNIDYPVD CCCHHHHHCCCCCCC | 59.63 | 22790023 | |
696 (in isoform 2) | Ubiquitination | - | 59.63 | 22790023 | |
697 (in isoform 2) | Ubiquitination | - | 25.53 | - | |
700 | Phosphorylation | KLVKNIDYPVDLEIS HHHHCCCCCCCHHHH | 11.02 | 23984901 | |
707 | Phosphorylation | YPVDLEISRELLSPG CCCCHHHHHHHHCCC | 15.44 | 23984901 | |
712 | Phosphorylation | EISRELLSPGIKNKN HHHHHHHCCCCCCCC | 33.43 | 26745281 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
330 | S | Phosphorylation | Kinase | ATM | Q62388 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBP10_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBP10_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PABP1_HUMAN | PABPC1 | physical | 23230274 | |
G3BP1_HUMAN | G3BP1 | physical | 23230274 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"The phagosomal proteome in interferon-gamma-activated macrophages."; Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.; Immunity 30:143-154(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570, AND MASSSPECTROMETRY. | |
"Specific phosphopeptide enrichment with immobilized titanium ionaffinity chromatography adsorbent for phosphoproteome analysis."; Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.; J. Proteome Res. 7:3957-3967(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570, AND MASSSPECTROMETRY. | |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-205 AND SER-570, ANDMASS SPECTROMETRY. | |
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570, AND MASSSPECTROMETRY. |